Psychiatry and Neurology, Neurology · Corinth, MS
NPI
1104844505
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
123 Alcorn Drive
Corinth, MS, 38834
Phone (662) 594-1799
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
4,191 services
Medicare patients, 2024
633
Average age 73
Drug cost, 2024
$2.3M
5,710 prescriptions
Company payments, 2025
$1,760
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew L Kerby was code 99232 (hospital e&m - subsequent), 565 times for 176 patients. In total Andrew L Kerby billed 4,191 services in 15 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 565 | 176 | $57.05 | $32K |
| 99214 Office E&M - Established | Office | 463 | 329 | $74.45 | $34K |
| 99291 Critical Care E&M | Facility | 264 | 67 | $154.32 | $41K |
| 99222 Hospital E&M - Initial | Facility | 232 | 214 | $91.72 | $21K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 205 | 65 | $45.08 | $9,242 |
| 99204 Office E&M - New | Office | 59 | 59 | $106.17 | $6,264 |
| 99215 Office E&M - Established | Office | 17 | 17 | $123.04 | $2,092 |
By year: 2022 $218K for 3,497 services; 2023 $161K for 1,981 services; 2024 $212K for 4,191 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew L Kerby prescribed most often to Medicare patients was Levetiracetam, with 429 prescriptions and refills. In total Andrew L Kerby wrote 5,710 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 429 | 604 | 85 | $9,356 |
| Gabapentin Generic | 319 | 383 | 60 | $5,929 |
| Memantine Hcl Generic | 293 | 362 | 58 | $3,876 |
| Diazepam Generic | 209 | 212 | 40 | $1,034 |
| Donepezil Hcl Generic | 204 | 284 | 40 | $1,787 |
| Lamotrigine Generic | 204 | 283 | 42 | $3,214 |
| Clonazepam Generic | 161 | 173 | 20 | $1,023 |
| Topiramate Generic | 146 | 214 | 31 | $2,138 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 136 | 211 | 27 | $3,476 |
| Lacosamide Generic | 132 | 164 | 23 | $9,138 |
| Tizanidine Hcl Generic | 113 | 159 | 24 | $2,372 |
| Primidone Generic | 112 | 156 | 21 | $1,556 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 90 | 90 | 11 | $2,264 |
| Trazodone Hcl Generic | 88 | 95 | 12 | $469 |
| Duloxetine Hcl Generic | 87 | 123 | 17 | $1,161 |
Brand drugs: - claims; generic drugs: 5,088 claims; opioid claims: 112.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew L Kerby $1,760 ($1,760 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novartis Pharmaceuticals Corporation with $265.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $265 |
| SK Life Science, Inc. | 10 | $220 |
| Biogen, Inc. BIIB | 9 | $196 |
| Eisai Inc. 4523.T | 9 | $172 |
| Abbvie Inc. ABBV | 14 | $168 |
| Lilly USA, LLC LLY | 7 | $144 |
| Argenx US, Inc. ARGX | 6 | $113 |
| Pfizer Inc. PFE | 6 | $108 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $88.7 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $69.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.